Since ketoprofen is eliminated by the kidneys and reduces renal blood flow, the dose of ketoprofen in patients with impaired renal function should be reduced and closely monitored.
Kaltrofen should be used cautiously in patients with hepatic dysfunction and patients with gastric hyperacidity disorders.
Administration with food or milk is advised to avoid minor adverse symptoms of the gastrointestinal tract.
Gel: Do not apply to the mucous membranes or eyes.
Caution should still be exercised in patients with a history of or active gastrointestinal bleeding, peptic ulcer, inflammatory disease of the gastrointestinal tract or severe renal impairment; although systemic effects are minimal.
KALTROFEN gel should not be use in children younger than 12 years of age unless otherwise directed by the doctor.
Should a skin rash occur after gel application, stop the treatment.
As is the case with other NSAID's, Ketoprofen does not cure the underlying disease.
Use in pregnancy & lactation: Kaltrofen is not recommended for use in pregnant and nursing women even though there is no record about embryopathic effects.
Gel: KALTROFEN gel should not be use in pregnant woman and during lactation.